Research Analysts’ upgrades for Wednesday, December 6th:

Advanced Emissions Solutions (NASDAQ:ADES) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

Tesoro (NYSE:ANDV) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

Atento (NYSE:ATTO) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

Cherokee (NASDAQ:CHKE) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

NorthStar Asset Management Group (NYSE:CLNS) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

DryShips (NASDAQ:DRYS) was upgraded by analysts at ValuEngine from a sell rating to a hold rating.

Foundation Medicine (NASDAQ:FMI) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $66.00 price target on the stock. According to Zacks, “Foundation Medicine, Inc. provides molecular information products primarily in the United States. The company offers FoundationOne(TM) a molecular information product for the analysis of routine cancer specimens in a clinical setting. Its molecular information platform generates actionable genomic information about a patient’s individual disease, enabling physicians to optimize treatments in clinical practice, and enabling biopharmaceutical companies to develop targeted oncology therapies. Foundation Medicine, Inc. is based in Cambridge, Massachusetts. “

Fox Factory (NASDAQ:FOXF) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $44.00 target price on the stock. According to Zacks, “Fox Factory Holding Corp. is a designer, manufacturer and marketer of suspension products used primarily on mountain bikes, side-by-side vehicles, on-road vehicles, off-road vehicles, all-terrain vehicles, snowmobiles, specialty vehicles and applications and motorcycles. Fox Factory Holding Corp. is headquartered in California. “

Global Blood Therapeutics (NASDAQ:GBT) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Global Blood Therapeutics, Inc. is a biopharmaceutical company which is engaged in discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. Its product candidate consists of GBT440 is an oral, once-daily prophylactic therapy for sickle cell disease which is in clinical trial. The company in addition to GBT is involved in research and development activities targeted hypoxemic pulmonary disorders, including idiopathic pulmonary fibrosis and hereditary angioedema. Global Blood Therapeutics, Inc. is based in South San Francisco, California. “

Gladstone Capital (NASDAQ:GLAD) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Gladstone Capital Corporation is a specialty finance company that invests in debt securities consisting primarily of senior term loans, senior subordinated loans, and junior subordinated loans in small and medium sized companies. The Company target small and medium sized private businesses that meet some or all of our criteria, including the potential for growth, adequate assets for loan collateral, experienced management teams with significant ownership interest in the business, adequate capitalization, profitable operations based on cash flow, substantial ownership by a buyout fund or a venture capital fund and potential opportunities for us to realize appreciation and gain liquidity in our equity position. “

Heineken (OTCMKTS:HEINY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Heineken N.V. is engaged in producing and distributing beverages. It offers beer, cider, soft drinks, and other beverages. The Company’s principal global brand is Heineken. Heineken N.V. is headquartered in Amsterdam, the Netherlands. “

Haverty Furniture Companies (NYSE:HVT) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Haverty Furniture Companies, Inc. (Havertys) is a full-service home furnishings retailer with over 100 showrooms in 16 states in the Southern and Midwestern regions providing its customers with a wide selection of quality merchandise in middle to upper-middle price ranges. Havertys is a true retailing institution. “

Halyard Health (NYSE:HYH) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $53.00 target price on the stock. According to Zacks, “Halyard Health, Inc. is a medical technology company. It is focused on advancing health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company sells surgical and infection prevention products for the operating room. Halyard offers products such as sterilization wraps, face masks, surgical drapes and gowns, closed suction catheters, pain pumps and enteral feeding tubes. It offers a range of medical device solutions including post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems, and enteral feeding tubes. Halyard Health, Inc. is headquartered in Alpharetta, Georgia. “

IHS Markit (NASDAQ:INFO) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $50.00 target price on the stock. According to Zacks, “IHS Markit Ltd. provides information, analytics and solutions to customers. It serves business, finance and government. IHS Markit Ltd., formerly known as Markit Ltd., is based in LONDON, United Kingdom. “

Summit Hotel Properties (NYSE:INN) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Summit Hotel Properties, Inc. is a publicly traded real estate investment trust focused primarily on owning premium-branded, select-service hotels in the upscale and upper midscale segments of the lodging industry. “

inTEST (NYSEAMERICAN:INTT) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $9.75 price target on the stock. According to Zacks, “InTEST Corporation is an independent designer, manufacturer and marketer of ATE interface solutions and temperature management products, which are used by semiconductor manufacturers to perform final testing of integrated circuits and wafers. The Company’s high-performance products are designed to enable semiconductor manufacturers to improve the speed, reliability, efficiency and profitability of IC test processes. Specific products include positioner and docking hardware products, temperature management systems and customized interface solutions. The Company has established strong relationships with semiconductor manufacturers globally, which it supports through a network of local offices. “

Invesco (NYSE:IVZ) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

J d Wetherspoon (OTCMKTS:JDWPY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “JD Wetherspoon Plc owns and operates pubs. The principal activity of the company is development and management of public houses. It operates primarily in United Kingdom. JD Wetherspoon Plc is headquartered in Watford, the United Kingdom. “

J.Jill (NYSE:JILL) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “J.Jill, Inc. operates as a specialty retailer of womens apparel. The Company offers sweaters, tops, pants, dresses, shorts, skirts, sleepwear and accessories. It markets through retail stores, website and catalog. J.Jill, Inc. is headquartered in Quincy, Massachusetts. “

Tesla (NASDAQ:TSLA) was upgraded by analysts at ValuEngine from a sell rating to a hold rating.

21Vianet Group (NASDAQ:VNET) was upgraded by analysts at ValuEngine from a sell rating to a hold rating.

Receive News & Ratings for Advanced Emissions Solutions Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Emissions Solutions Inc and related companies with MarketBeat.com's FREE daily email newsletter.